Sugi Predict

Sugi Predict / Compounds / SCHEMBL12737553

SCHEMBL12737553

SCHEMBL12737553

C=C(C)C(=O)OCCOC(=O)C1CN(C2CC2)c2cc(N3CCNCC3)c(F)cc2C1=O

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TOP2A P11388 2/20 0.47
▸ LMNA P02545 3/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ TOP2B Q02880 1/20 0.37
▸ HTT P42858 2/20 0.33
▸ BRD4 O60885 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ CYP2J2 P51589 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ OPRL1 P41146 2/20 0.32
▸ MAPT P10636 2/20 0.31
▸ GAA P10253 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ FFAR4 Q5NUL3 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19656603 0.93 TOP2A (0.47) TOP2ALMNAALDH1A1KDM4EHPGD
SCHEMBL16534602 0.88 TOP2A (0.47) TOP2ALMNAALDH1A1KDM4EHPGD
SCHEMBL16329562 0.80 TOP2A (0.55) TOP2ALMNAALDH1A1KDM4EHPGD
SCHEMBL17775397 0.69 TOP2A (0.42) TOP2ALMNAALDH1A1KDM4EHPGD
SCHEMBL13424582 0.68 KDM4E (0.31) LMNAALDH1A1KDM4EHPGDHSD17B10
SCHEMBL10959800 0.68 ALDH1A1 (0.46) TOP2ALMNAALDH1A1KDM4EHPGD
SCHEMBL29724074 0.67 TOP2A (0.50) TOP2ALMNAALDH1A1KDM4EHPGD
SCHEMBL28776450 0.67 TOP2A (0.50) TOP2ALMNAALDH1A1KDM4EHPGD
SCHEMBL22015414 0.67 TOP2A (0.44) TOP2ALMNAALDH1A1KDM4EHPGD
SCHEMBL21894264 0.66 TOP2A (0.42) TOP2ALMNAALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10039864-B2 Oligofluorinated cross-linked polymers and uses thereof INTERFACE BIOLOGICS, INC. (CA) 2018-08-07 — — US disclosed
US-10039864-B2 Oligofluorinated cross-linked polymers and uses thereof INTERFACE BIOLOGICS, INC. (CA) 2018-08-07 — — US disclosed
EP-2203498-B1 OLIGOFLUORINATED CROSS-LINKED POLYMERS AND USES THEREOF INTERFACE BIOLOGICS INC (CA) 2017-12-06 — — EP disclosed
US-20170340781-A1 OLIGOFLUORINATED CROSS-LINKED POLYMERS AND USES THEREOF Evonik Canada Inc. (CA) 2017-11-30 — — US disclosed
US-20170340781-A1 OLIGOFLUORINATED CROSS-LINKED POLYMERS AND USES THEREOF Evonik Canada Inc. (CA) 2017-11-30 — — US disclosed
US-20110091508-A1 OLIGOFLUORINATED CROSS-LINKED POLYMERS AND USES THEREOF Interface Biologics ,Inc. (CA) 2011-04-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110091508-A1 OLIGOFLUORINATED CROSS-LINKED POLYMERS AND USES THEREOF MACF1, PUF60, PFAS TOP2A 911/4885LMNA 3055/4885ALDH1A1 2921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.